Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Clinicopathological study of male breast carcinoma: 24 years of experience.

Shah P, Robbani I, Shah O.

Ann Saudi Med. 2009 Jul-Aug;29(4):288-93.

2.

Breast cancer in men.

Giordano SH, Buzdar AU, Hortobagyi GN.

Ann Intern Med. 2002 Oct 15;137(8):678-87. Review.

PMID:
12379069
3.

BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy.

Ottini L, Rizzolo P, Zanna I, Falchetti M, Masala G, Ceccarelli K, Vezzosi V, Gulino A, Giannini G, Bianchi S, Sera F, Palli D.

Breast Cancer Res Treat. 2009 Aug;116(3):577-86. doi: 10.1007/s10549-008-0194-z. Epub 2008 Sep 26.

PMID:
18819001
4.

BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.

Ottini L, Masala G, D'Amico C, Mancini B, Saieva C, Aceto G, Gestri D, Vezzosi V, Falchetti M, De Marco M, Paglierani M, Cama A, Bianchi S, Mariani-Costantini R, Palli D.

Cancer Res. 2003 Jan 15;63(2):342-7.

5.

BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study.

de Juan I, Palanca S, Domenech A, Feliubadaló L, Segura Á, Osorio A, Chirivella I, de la Hoya M, Sánchez AB, Infante M, Tena I, Díez O, Garcia-Casado Z, Vega A, Teulé À, Barroso A, Pérez P, Durán M, Carrasco E, Juan-Fita MJ, Murria R, Llop M, Barragan E, Izquierdo Á, Benítez J, Caldés T, Salas D, Bolufer P.

Fam Cancer. 2015 Dec;14(4):505-13. doi: 10.1007/s10689-015-9814-z.

PMID:
26026974
6.

Clinicopathological and Immunohistochemical Characteristics in Male Breast Cancer: A Retrospective Case Series.

Masci G, Caruso M, Caruso F, Salvini P, Carnaghi C, Giordano L, Miserocchi V, Losurdo A, Zuradelli M, Torrisi R, Di Tommaso L, Tinterri C, Testori A, Garcia-Etienne CA, Gatzemeier W, Santoro A.

Oncologist. 2015 Jun;20(6):586-92. doi: 10.1634/theoncologist.2014-0243. Epub 2015 May 6.

7.

Clinicopathological study of male breast cancer in Nigerians and a review of the literature.

Olu-Eddo AN, Momoh MI.

Nig Q J Hosp Med. 2010 Jul-Sep;20(3):121-4. Review.

PMID:
21033319
8.

[Breast carcinoma in the man. Current results from the viewpoint of clinic and pathology].

Prechtel K, Prechtel V.

Pathologe. 1997 Jan;18(1):45-52. German.

PMID:
9157404
9.

Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status in invasive breast cancer: a 3,198 cases study at National Cancer Center, China.

Zhu X, Ying J, Wang F, Wang J, Yang H.

Breast Cancer Res Treat. 2014 Oct;147(3):551-5. doi: 10.1007/s10549-014-3136-y. Epub 2014 Sep 19.

PMID:
25234844
10.

[Male breast cancer: prognostic factors, diagnosis and treatment: a multi-institutional survey of 95 cases].

Oger AS, Boukerrou M, Cutuli B, Campion L, Rousseau E, Bussières E, Raro P, Classe JM.

Gynecol Obstet Fertil. 2015 Apr;43(4):290-6. doi: 10.1016/j.gyobfe.2015.02.010. Epub 2015 Mar 26. French.

PMID:
25818033
11.

Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India.

Saxena S, Chakraborty A, Kaushal M, Kotwal S, Bhatanager D, Mohil RS, Chintamani C, Aggarwal AK, Sharma VK, Sharma PC, Lenoir G, Goldgar DE, Szabo CI.

BMC Med Genet. 2006 Oct 4;7:75.

12.

Phenotypic analysis of familial breast cancer: comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer.

Aloraifi F, Alshehhi M, McDevitt T, Cody N, Meany M, O'Doherty A, Quinn CM, Green AJ, Bracken A, Geraghty JG.

Eur J Surg Oncol. 2015 May;41(5):641-6. doi: 10.1016/j.ejso.2015.01.021. Epub 2015 Feb 17.

PMID:
25736863
13.

Breast cancer risk among male BRCA1 and BRCA2 mutation carriers.

Tai YC, Domchek S, Parmigiani G, Chen S.

J Natl Cancer Inst. 2007 Dec 5;99(23):1811-4. Epub 2007 Nov 27.

14.

[Male breast cancer: history, epidemiology, genetic and histopathology].

Leinung S, Horn LC, Backe J.

Zentralbl Chir. 2007 Oct;132(5):379-85. Review. German.

PMID:
17907078
15.

Male breast cancer: A single institute experience.

Gogia A, Raina V, Deo SV, Shukla NK, Mohanti BK.

Indian J Cancer. 2015 Oct-Dec;52(4):526-9. doi: 10.4103/0019-509X.178399.

17.

Frequency of distribution of oestrogen and progesterone receptors positivities in breast cancer cases in Benin-City, Nigeria.

Ugiagbe EE, Obaseki DE, Oluwasola AO, Olu-Eddo AN, Akhiwu WO.

Niger Postgrad Med J. 2012 Mar;19(1):19-24.

PMID:
22430597
18.

Large genomic rearrangement in BRCA1 and BRCA2 and clinical characteristics of men with breast cancer in the United States.

Tchou J, Ward MR, Volpe P, Palma MD, Medina CA, Sargen M, Sonnad SS, Godwin AK, Daly M, Winchester DJ, Garber J, Weber BL, Domchek S, Nathanson KL.

Clin Breast Cancer. 2007 Jun;7(8):627-33.

PMID:
17592676
19.

Male breast carcinoma: correlation of ER, PR, Ki-67, Her2-Neu, and p53 with treatment and survival, a study of 65 cases.

Wang-Rodriguez J, Cross K, Gallagher S, Djahanban M, Armstrong JM, Wiedner N, Shapiro DH.

Mod Pathol. 2002 Aug;15(8):853-61.

20.

Clinical and epidemiologic profile of breast cancer in Tanzania.

Burson AM, Soliman AS, Ngoma TA, Mwaiselage J, Ogweyo P, Eissa MS, Dey S, Merajver SD.

Breast Dis. 2010;31(1):33-41. doi: 10.3233/BD-2009-0296.

Supplemental Content

Support Center